Blepharospasm

ByRichard C. Allen, MD, PhD, University of Texas at Austin Dell Medical School
Reviewed BySunir J. Garg, MD, FACS, Thomas Jefferson University
Reviewed/Revised Modified Jan 2026
v954152
View Patient Education

Blepharospasm is a focal dystonia characterized by spasm of muscles around the eye leading to involuntary blinking and sustained eyelid closure. Diagnosis is clinical. Treatment is symptomatic with botulinum toxin injections. Adjunctive therapies include tinted sunglasses and alleviating maneuvers such as touching the face or covering the eyes.

The cause of blepharospasm is most often unknown (1). It affects women more than men and tends to occur in families (2). It is a chronic neurological movement disorder that is classified as a focal dystonia. Rarely, blepharospasm may be secondary to eye disorders, including those that cause ocular irritation (eg, trichiasis, an inward growing eye lash), corneal foreign body, keratoconjunctivitis sicca (dry eye), and systemic neurologic diseases that cause dystonias (eg, Parkinson disease).

Symptoms are involuntary blinking that can progress to sustained spasms and difficulty opening the eyes; in severe cases, patients cannot open their eyes. Spasms may be made worse by fatigue, bright light, and anxiety.

The diagnosis is clinical, based on characteristic bilateral, involuntary, repetitive spasms of the orbicularis oculi muscles, often accompanied by increased blinking and difficulty keeping the eyes open.

Treatment of blepharospasm involves injecting botulinum toxin type A into the eyelid muscles (orbicularis oculi); treatment must be repeated in most instances (3). Anxiolytics may help. Surgery to resect the periorbital muscles is also effective but, because of potential complications, is considered only if botulinum toxin is ineffective. Sunglasses, particularly with FL-41 tinted lenses, help decrease the light sensitivity that may cause or accompany blepharospasm (4). Temporary relief can also be obtained by alleviating maneuvers such as touching the face, covering the eyes, singing, or yawning (5).

General references

  1. 1. Zhu L, Meng H, Zhang W, et al. The pathogenesis of blepharospasm. Front Neurol. 2024;14:1336348. Published 2024 Jan 11. doi:10.3389/fneur.2023.1336348

  2. 2. Peckham EL, Lopez G, Shamim EA, et al. Clinical features of patients with blepharospasm: a report of 240 patients. Eur J Neurol. 2011;18(3):382-386. doi:10.1111/j.1468-1331.2010.03161.x

  3. 3. Simpson DM, Hallett M, Ashman EJ, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(19):1818-1826.

  4. 4. Blackburn MK, Lamb RD, Digre KB, et al. FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology. 2009;116(5):997-1001. doi:10.1016/j.ophtha.2008.12.031

  5. 5. Kilduff CLS, Casswell EJ, Salam T, et al: Use of alleviating maneuvers for periocular facial dystonias. JAMA Ophthalmol 134:1247-1252, 2016. doi: 10.1001/jamaophthalmol.2016.3277

quizzes_lightbulb_red
Test your KnowledgeTake a Quiz!
IOS ANDROID
IOS ANDROID
iOS ANDROID